Mostrar el registro sencillo del ítem
Prevalence of four statin benefit groups in a population of the Caribbean region of Colombia
dc.contributor.author | Miranda, P. A. | spa |
dc.contributor.author | Salcedo Mejía, F. E. | spa |
dc.contributor.author | Paz-Wilches, J. | spa |
dc.contributor.author | De La Hoz, F. | spa |
dc.contributor.author | Alvis-Guzmán, N. | spa |
dc.date.accessioned | 2019-08-28T16:14:46Z | |
dc.date.available | 2019-08-28T16:14:46Z | |
dc.date.issued | 2019 | |
dc.identifier.uri | http://hdl.handle.net/11323/5210 | spa |
dc.description.abstract | Objectives: To estimate the prevalence of four Statin Benefit Groups (SBG) according to the 2018 ACC/AHA Multisociety Guideline on the Management of Blood Cholesterol, in a population of the Caribbean region of Colombia enrolled to DTC program Mutual SER-EPS in 2015 Methods: Data on a history of hyperlipidemia was collected by study investigators at including adults patients enrolled to DTC program Mutual SER-EPS in 2015 (N = 64,667) with ICD-10 diagnosis of hyperlipidemia (E78), or with a personal history of hyperlipidemia; or with abnormal lipid profile; or patients under treatment with lipid-lowering drugs. The four SBG were comprised adult patients $21 years of age with clinical atherosclerotic cardiovascular disease (ASCVD) (SBG1); adults $21 years of age with LDL-C $190 mg/dL (not due to secondary modifiable causes) (SBG2); adults aged 40 to 75 years without ASCVD, but with diabetes and with LDL-C 70 to 189 mg/dL (SBG3); and adults ages 40 to 75 years without ASCVD or diabetes, with LDL-C 70 to 189 mg/dL, and an estimated 10-year risk for ASCVD of $ 20% as determined by the Framingham Risk Score (SBG4). The prevalence of statin use by SBG and factors associated with statin use were estimated. Results: The prevalence of SBG1, SBG2, SBG3 and SBG4 in patients enrolled to DTC program Mutual SER-EPS in 2015 were 4.6% (2,985), 0.5% (337), 2.5% (1,633) and 1.3% (891), respectively. The prevalence of statin use in SBG1, SBG2, SBG3 and SBG4 were 69.1% (2,064), 40.6% (137), 47% (768) and 59.1% (463), respectively. Arterial hypertension (OR: 2.70; 95% IC 1.70-4.28) and personal history of ASCVD (OR: 3.43; 95% IC 2.15-5.46) were very significantly associated with statin use. Conclusions: The prevalence of SBG and statin use in patients enrolled to DTC program Mutual SEREPS in 2015 were 9% (5,846) and 58.7% (3,432), respectively. | spa |
dc.language.iso | eng | |
dc.publisher | Universidad de la Costa | spa |
dc.rights | CC0 1.0 Universal | spa |
dc.rights.uri | http://creativecommons.org/publicdomain/zero/1.0/ | spa |
dc.subject | Statin | spa |
dc.subject | Cholesterol | spa |
dc.subject | Región Caribe | spa |
dc.subject | Colombia | spa |
dc.title | Prevalence of four statin benefit groups in a population of the Caribbean region of Colombia | spa |
dc.type | Pre-Publicación | spa |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
dc.identifier.instname | Corporación Universidad de la Costa | spa |
dc.identifier.reponame | REDICUC - Repositorio CUC | spa |
dc.identifier.repourl | https://repositorio.cuc.edu.co/ | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_816b | spa |
dc.type.content | Text | spa |
dc.type.driver | info:eu-repo/semantics/preprint | spa |
dc.type.redcol | http://purl.org/redcol/resource_type/ARTOTR | spa |
dc.type.version | info:eu-repo/semantics/acceptedVersion | spa |
dc.type.coarversion | http://purl.org/coar/version/c_ab4af688f83e57aa | spa |
dc.rights.coar | http://purl.org/coar/access_right/c_abf2 | spa |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos científicos [3154]
Artículos de investigación publicados por miembros de la comunidad universitaria.